Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1987 Apr;79(4):1144–1152. doi: 10.1172/JCI112931

Molecular cloning of a polymorphic DNA endonuclease fragment associates insulin-dependent diabetes mellitus with HLA-DQ.

B Michelsen, A Lernmark
PMCID: PMC424296  PMID: 2881947

Abstract

A BamHI 3.7-kilobase (kb) fragment detected by an HLA-DQ beta-chain complementary DNA (cDNA) probe and negatively associated with insulin-dependent diabetes mellitus (IDDM) was cloned and sequenced to localize the polymorphism to BamHI sites in intervening sequences of an HLA-DQ beta-chain gene. A probe of the first intervening sequence (IVS 1) showed the BamHI 3.7-kb fragment in 6 of 17 HLA-DR3/4 controls but in 0 of 13 DR-identical IDDM patients. All IDDM patients (13 of 13) had BamHI fragments of 12 and 4 kb, detected in 9 of 17 controls (P less than 0.02). The simple restriction fragment length polymorphism pattern of the IVS 1 probe was exploited by comparing 113 IDDM patients with 177 healthy controls to show increased prevalences in IDDM of the 12-kb (P less than 0.0001) and 4-kb (P less than 0.0001) fragments. In IDDM patients younger than 20 yr at onset, 98% were 12- and/or 4-kb positive, compared with 63% of controls (P less than 0.0001), giving a relative risk of 91.8 for individuals with both fragments. The 12-kb fragment was linked to HLA-DR4, and the 4-kb fragment to HLA-DR3. Both serologic markers were split and a non-DR3/non-DR4 IDDM patient was 4-kb positive. HLA-DQ seems therefore closer, than HLA-DR, to an IDDM susceptibility gene.

Full text

PDF
1144

Images in this article

1145Image
on p.1145
1148Image
on p.1148
1148Image
on p.1148

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andersson M., Böhme J., Andersson G., Möller E., Thorsby E., Rask L., Peterson P. A. Genomic hybridization with class II transplantation antigen cDNA probes as a complementary technique in tissue typing. Hum Immunol. 1984 Oct;11(2):57–67. doi: 10.1016/0198-8859(84)90045-4. [DOI] [PubMed] [Google Scholar]
  2. Babbitt B. P., Allen P. M., Matsueda G., Haber E., Unanue E. R. Binding of immunogenic peptides to Ia histocompatibility molecules. 1985 Sep 26-Oct 2Nature. 317(6035):359–361. doi: 10.1038/317359a0. [DOI] [PubMed] [Google Scholar]
  3. Bach F. H., Rich S. S., Barbosa J., Segall M. Insulin-dependent diabetes--associated HLA-D region encoded determinants. Hum Immunol. 1985 Feb;12(2):59–64. doi: 10.1016/0198-8859(85)90343-x. [DOI] [PubMed] [Google Scholar]
  4. Baekkeskov S., Nielsen J. H., Marner B., Bilde T., Ludvigsson J., Lernmark A. Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins. Nature. 1982 Jul 8;298(5870):167–169. doi: 10.1038/298167a0. [DOI] [PubMed] [Google Scholar]
  5. Boss J. M., Strominger J. L. Cloning and sequence analysis of the human major histocompatibility complex gene DC-3 beta. Proc Natl Acad Sci U S A. 1984 Aug;81(16):5199–5203. doi: 10.1073/pnas.81.16.5199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Breathnach R., Chambon P. Organization and expression of eucaryotic split genes coding for proteins. Annu Rev Biochem. 1981;50:349–383. doi: 10.1146/annurev.bi.50.070181.002025. [DOI] [PubMed] [Google Scholar]
  7. Bruserud O., Jervell J., Thorsby E. HLA-DR3 and -DR4 control T-lymphocyte responses to mumps and Coxsackie B4 virus: studies on patients with type 1 (insulin-dependent) diabetes and healthy subjects. Diabetologia. 1985 Jul;28(7):420–426. doi: 10.1007/BF00280884. [DOI] [PubMed] [Google Scholar]
  8. Böhme J., Andersson M., Andersson G., Möller E., Peterson P. A., Rask L. HLA-DR beta genes vary in number between different DR specificities, whereas the number of DQ beta genes is constant. J Immunol. 1985 Sep;135(3):2149–2155. [PubMed] [Google Scholar]
  9. Böhme J., Carlsson B., Wallin J., Möller E., Persson B., Peterson P. A., Rask L. Only one DQ-beta restriction fragment pattern of each DR specificity is associated with insulin-dependent diabetes. J Immunol. 1986 Aug 1;137(3):941–947. [PubMed] [Google Scholar]
  10. Cahill G. F., Jr, McDevitt H. O. Insulin-dependent diabetes mellitus: the initial lesion. N Engl J Med. 1981 Jun 11;304(24):1454–1465. doi: 10.1056/NEJM198106113042403. [DOI] [PubMed] [Google Scholar]
  11. Chen E. Y., Seeburg P. H. Supercoil sequencing: a fast and simple method for sequencing plasmid DNA. DNA. 1985 Apr;4(2):165–170. doi: 10.1089/dna.1985.4.165. [DOI] [PubMed] [Google Scholar]
  12. Christau B., Kromann H., Christy M., Andersen O. O., Nerup J. Incidence of insulin-dependent diabetes mellitus (0--29 years at onset) in Denmark. Acta Med Scand Suppl. 1979;624:54–60. doi: 10.1111/j.0954-6820.1979.tb00719.x. [DOI] [PubMed] [Google Scholar]
  13. Cohen-Haguenauer O., Robbins E., Massart C., Busson M., Deschamps I., Hors J., Lalouel J. M., Dausset J., Cohen D. A systematic study of HLA class II-beta DNA restriction fragments in insulin-dependent diabetes mellitus. Proc Natl Acad Sci U S A. 1985 May;82(10):3335–3339. doi: 10.1073/pnas.82.10.3335. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Cohen D., Cohen O., Marcadet A., Massart C., Lathrop M., Deschamps I., Hors J., Schuller E., Dausset J. Class II HLA-DC beta-chain DNA restriction fragments differentiate among HLA-DR2 individuals in insulin-dependent diabetes and multiple sclerosis. Proc Natl Acad Sci U S A. 1984 Mar;81(6):1774–1778. doi: 10.1073/pnas.81.6.1774. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Cohen D., Le Gall I., Marcadet A., Font M. P., Lalouel J. M., Dausset J. Clusters of HLA class II beta restriction fragments describe allelic series. Proc Natl Acad Sci U S A. 1984 Dec;81(24):7870–7874. doi: 10.1073/pnas.81.24.7870. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Dahlquist G., Blom L., Holmgren G., Hägglöf B., Larsson Y., Sterky G., Wall S. The epidemiology of diabetes in Swedish children 0-14 years--a six-year prospective study. Diabetologia. 1985 Nov;28(11):802–808. doi: 10.1007/BF00291068. [DOI] [PubMed] [Google Scholar]
  17. Deininger P. L., Jolly D. J., Rubin C. M., Friedmann T., Schmid C. W. Base sequence studies of 300 nucleotide renatured repeated human DNA clones. J Mol Biol. 1981 Sep 5;151(1):17–33. doi: 10.1016/0022-2836(81)90219-9. [DOI] [PubMed] [Google Scholar]
  18. Foulis A. K., Stewart J. A. The pancreas in recent-onset type 1 (insulin-dependent) diabetes mellitus: insulin content of islets, insulitis and associated changes in the exocrine acinar tissue. Diabetologia. 1984 Jun;26(6):456–461. doi: 10.1007/BF00262221. [DOI] [PubMed] [Google Scholar]
  19. Gepts W. Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes. 1965 Oct;14(10):619–633. doi: 10.2337/diab.14.10.619. [DOI] [PubMed] [Google Scholar]
  20. Gorsuch A. N., Spencer K. M., Lister J., McNally J. M., Dean B. M., Bottazzo G. F., Cudworth A. G. Evidence for a long prediabetic period in type I (insulin-dependent) diabetes mellitus. Lancet. 1981 Dec 19;2(8260-61):1363–1365. doi: 10.1016/s0140-6736(81)92795-1. [DOI] [PubMed] [Google Scholar]
  21. Gregersen P. K., Shen M., Song Q. L., Merryman P., Degar S., Seki T., Maccari J., Goldberg D., Murphy H., Schwenzer J. Molecular diversity of HLA-DR4 haplotypes. Proc Natl Acad Sci U S A. 1986 Apr;83(8):2642–2646. doi: 10.1073/pnas.83.8.2642. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Götz H., Kratzin H., Thinnes F. P., Yang C., Kruse T., Pauly E., Kölbel S., Egert G., Wernet P., Hilschmann N. Primary structure of human class II histocompatibility antigens 3rd communication. Amino acid sequence comparison between DR and DC subclass antigens derived from a lymphoblastoid B cell line homozygous at the HLA loci (HLA-A3,3; B7,7; Dw2,2; DR2,2: MT1,1; Dc1,1: MB1,1). Hoppe Seylers Z Physiol Chem. 1983 Jun;364(6):749–755. doi: 10.1515/bchm2.1983.364.1.749. [DOI] [PubMed] [Google Scholar]
  23. Hanahan D. Studies on transformation of Escherichia coli with plasmids. J Mol Biol. 1983 Jun 5;166(4):557–580. doi: 10.1016/s0022-2836(83)80284-8. [DOI] [PubMed] [Google Scholar]
  24. Henikoff S. Unidirectional digestion with exonuclease III creates targeted breakpoints for DNA sequencing. Gene. 1984 Jun;28(3):351–359. doi: 10.1016/0378-1119(84)90153-7. [DOI] [PubMed] [Google Scholar]
  25. Johnston C., Pyke D. A., Cudworth A. G., Wolf E. HLA-DR typing in identical twins with insulin-dependent diabetes: difference between concordant and discordant pairs. Br Med J (Clin Res Ed) 1983 Jan 22;286(6361):253–255. doi: 10.1136/bmj.286.6361.253. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Larhammar D., Hyldig-Nielsen J. J., Servenius B., Andersson G., Rask L., Peterson P. A. Exon-intron organization and complete nucleotide sequence of a human major histocompatibility antigen DC beta gene. Proc Natl Acad Sci U S A. 1983 Dec;80(23):7313–7317. doi: 10.1073/pnas.80.23.7313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Larhammar D., Schenning L., Gustafsson K., Wiman K., Claesson L., Rask L., Peterson P. A. Complete amino acid sequence of an HLA-DR antigen-like beta chain as predicted from the nucleotide sequence: similarities with immunoglobulins and HLA-A, -B, and -C antigens. Proc Natl Acad Sci U S A. 1982 Jun;79(12):3687–3691. doi: 10.1073/pnas.79.12.3687. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Michelsen B., Kastern W., Lernmark A., Owerbach D. Identification of an HLA-DQ beta-chain related genomic sequence associated with insulin-dependent diabetes. Biomed Biochim Acta. 1985;44(1):33–36. [PubMed] [Google Scholar]
  29. Nepom B. S., Nepom G. T., Mickelson E., Antonelli P., Hansen J. A. Electrophoretic analysis of human HLA-DR antigens from HLA-DR4 homozygous cell lines: correlation between beta-chain diversity and HLA-D. Proc Natl Acad Sci U S A. 1983 Nov;80(22):6962–6966. doi: 10.1073/pnas.80.22.6962. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Owerbach D., Hägglöf B., Lernmark A., Holmgren G. Susceptibility to insulin-dependent diabetes defined by restriction enzyme polymorphism of HLA-D region genomic DNA. Diabetes. 1984 Oct;33(10):958–965. doi: 10.2337/diab.33.10.958. [DOI] [PubMed] [Google Scholar]
  31. Owerbach D., Lernmark A., Platz P., Ryder L. P., Rask L., Peterson P. A., Ludvigsson J. HLA-D region beta-chain DNA endonuclease fragments differ between HLA-DR identical healthy and insulin-dependent diabetic individuals. Nature. 1983 Jun 30;303(5920):815–817. doi: 10.1038/303815a0. [DOI] [PubMed] [Google Scholar]
  32. Owerbach D., Lernmark A., Rask L., Peterson P. A., Platz P., Svejgaard A. Detection of HLA-D/DR-related DNA polymorphism in HLA-D homozygous typing cells. Proc Natl Acad Sci U S A. 1983 Jun;80(12):3758–3761. doi: 10.1073/pnas.80.12.3758. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Papadopoulos G., Lernmark A. The immune response in individuals with HLA-DR specificities conferring susceptibility to insulin-dependent diabetes--a hypothesis. Diabetes Res. 1984 May;1(1):3–11. [PubMed] [Google Scholar]
  34. Platz P., Jakobsen B. K., Morling N., Ryder L. P., Svejgaard A., Thomsen M., Christy M., Kromann H., Benn J., Nerup J. HLA-D and -DR antigens in genetic analysis of insulin dependent diabetes mellitus. Diabetologia. 1981 Aug;21(2):108–115. doi: 10.1007/BF00251276. [DOI] [PubMed] [Google Scholar]
  35. Reinsmoen N. L., Bach F. H. Five HLA-D clusters associated with HLA-DR4. Hum Immunol. 1982 Jun;4(3):249–258. doi: 10.1016/0198-8859(82)90040-4. [DOI] [PubMed] [Google Scholar]
  36. Rossini A. A., Mordes J. P., Like A. A. Immunology of insulin-dependent diabetes mellitus. Annu Rev Immunol. 1985;3:289–320. doi: 10.1146/annurev.iy.03.040185.001445. [DOI] [PubMed] [Google Scholar]
  37. Schenning L., Larhammar D., Bill P., Wiman K., Jonsson A. K., Rask L., Peterson P. A. Both alpha and beta chains of HLA-DC class II histocompatibility antigens display extensive polymorphism in their amino-terminal domains. EMBO J. 1984 Feb;3(2):447–452. doi: 10.1002/j.1460-2075.1984.tb01826.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Sheehy M. J., Rowe J. R., MacDonald M. J. A particular subset of HLA-DR4 accounts for all or most of the DR4 association in type I diabetes. Diabetes. 1985 Sep;34(9):942–944. doi: 10.2337/diab.34.9.942. [DOI] [PubMed] [Google Scholar]
  39. Srikanta S., Ganda O. P., Eisenbarth G. S., Soeldner J. S. Islet-cell antibodies and beta-cell function in monozygotic triplets and twins initially discordant for Type I diabetes mellitus. N Engl J Med. 1983 Feb 10;308(6):322–325. doi: 10.1056/NEJM198302103080607. [DOI] [PubMed] [Google Scholar]
  40. Tilanus M. G., Morolli B., van Eggermond M. C., Schreuder G. M., de Vries R. R., Giphart M. J. Dissection of HLA class II haplotypes in HLA-DR4 homozygous individuals. Immunogenetics. 1986;23(5):333–340. doi: 10.1007/BF00398798. [DOI] [PubMed] [Google Scholar]
  41. Wolf E., Spencer K. M., Cudworth A. G. The genetic susceptibility to type 1 (insulin-dependent) diabetes: analysis of the HLA-DR association. Diabetologia. 1983 Apr;24(4):224–230. doi: 10.1007/BF00282704. [DOI] [PubMed] [Google Scholar]
  42. Yanisch-Perron C., Vieira J., Messing J. Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. Gene. 1985;33(1):103–119. doi: 10.1016/0378-1119(85)90120-9. [DOI] [PubMed] [Google Scholar]
  43. Yoon J. W., Austin M., Onodera T., Notkins A. L. Isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N Engl J Med. 1979 May 24;300(21):1173–1179. doi: 10.1056/NEJM197905243002102. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES